
Breast Cancer Now Biobank
https://breastcancernow.org/our-research/information-for-researchers/apply-to-our-biobank/
The Breast Cancer Now Biobank (BCNB) is the UK’s first ever national breast cancer biobank and provides high-quality, biomaterials, data and images from breast cancer patients and individuals without breast cancer. The BCNB provides the breadth of materials needed for breast cancer research, ranging from serum samples, through frozen and fixed tissue samples to isolated breast cell populations. We help the research community to raise the standard of breast cancer research and facilitate the coordinated translation of scientific findings into the clinical setting. Breast Cancer Now provides funding to four leading research institutions to run the BCNTB. All centres (listed below) are licensed by the Human Tissue Authority: • Barts Cancer Institute, Queen Mary University of London (Lead Operational Centre) • University of Aberdeen • University of Sheffield • Cardiff University
Services
- Access to the full pathology archive
- Cell culture
- Data analytics
- Digital imaging
- Immunohistochemistry - staining
- Tissue micro array creation
- Nucleic acid extraction
Existing samples:
- Malignant tumor of breast (disorder)
Bespoke collection capabilities:
- Malignant tumor of breast (disorder)
Contact Information
- Email:
- biobank@breastcancernow.org
- Address:
-
Sixth Floor
The White Chapel Building
10 Whitechapel High Street
London
Greater London
E1 8QS
England
Last Updated: 02/10/2025
Annual Statistics
Year | Access Requests Received | Access Requests Approved | ||||
---|---|---|---|---|---|---|
Internal | External | Commercial | Internal | External | Commercial | |
2015 | N/A | N/A | N/A | N/A | N/A | N/A |
2016 | N/A | N/A | N/A | N/A | N/A | N/A |
2017 | N/A | N/A | N/A | N/A | N/A | N/A |
2018 | N/A | N/A | N/A | N/A | N/A | N/A |
2019 | N/A | N/A | N/A | N/A | N/A | N/A |
2020 | N/A | N/A | N/A | N/A | N/A | N/A |
2021 | N/A | N/A | N/A | N/A | N/A | N/A |
2022 | N/A | N/A | N/A | N/A | N/A | N/A |
2023 | N/A | N/A | N/A | N/A | N/A | N/A |
2024 | N/A | N/A | N/A | N/A | N/A | N/A |
2025 | N/A | N/A | N/A | N/A | N/A | N/A |